New hope for tough prostate cancer: drug combo trial begins
NCT ID NCT07287150
First seen Jan 10, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study tests if a combination of two drugs (inavolisib plus enzalutamide) works better than standard treatments for men with a certain type of advanced prostate cancer that no longer responds to hormone therapy. About 100 men will take part. The goal is to see if the combo can slow cancer growth and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Asan Medical Center.
RECRUITINGSeoul, 05505, South Korea
-
Box Hill Hospital
RECRUITINGBox Hill, Victoria, 3128, Australia
-
C.H. Regional Reina Sofia - PPDS
RECRUITINGCórdoba, 14004, Spain
-
CEPHO - Centro de Estudos e Pesquisas em Hematologia e Oncologia
RECRUITINGSanto André, São Paulo, 09060-650, Brazil
-
Carolina Urologic Research Center
RECRUITINGMyrtle Beach, South Carolina, 29572-4607, United States
-
Centre Léon Bérard
RECRUITINGLyon, 69008, France
-
Centre de recherche du Centre Hospitalier de l'Universite de Montreal
RECRUITINGMontreal, Quebec, H2X 0A9, Canada
-
Holden Comprehensive Cancer Center
RECRUITINGIowa City, Iowa, 52242-1009, United States
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Irmandade Da Santa Casa de Misericordia de Porto Alegre
RECRUITINGPorto Alegre, Rio Grande do Sul, 90035-074, Brazil
-
Jewish General Hospital
RECRUITINGMontreal, Quebec, H3T 1E2, Canada
-
Montefiore Einstein Cancer Center
RECRUITINGThe Bronx, New York, 10461, United States
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
Royal Brisbane & Womens Hospital
RECRUITINGHerston, Queensland, 4006, Australia
-
Samsung Medical Center
RECRUITINGSeoul, 06351, South Korea
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, Gyeonggido, 13620, South Korea
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
-
Severance Hospital, Yonsei University Health System
RECRUITINGSeoul, 03722, South Korea
-
Sunshine Coast University Hospital
RECRUITINGBirtinya, Queensland, 4575, Australia
-
UCSF
RECRUITINGSan Francisco, California, 94115, United States
Conditions
Explore the condition pages connected to this study.